查詢結果分析
相關文獻
- 乳癌婦女化療引起閉經之現象及其更年期症狀表現
- 文獻回顧乳癌婦女接受紫杉醇治療引發周邊神經病變之現況及其評估工具
- Successful Treatment of a Bulky Seminoma in an Abdominal Undescended Testis: A Case Report
- Ifosfamide-Based Chemotherapy for Previously Treated Lung Cancer Patients
- Treatment of Ultra-High Risk Gestational Trophoblastic Disease by an EMA/CE Regimen
- The Experience of Combination of Chemotherapy and Surgery in Treatment of Advanced Nonseminomatous Germ Cell Tumor of the Testis
- Malignant Primary Extragonadal Germ Cell Tumors of Mediastinum--An Analysis of Clinical and Radiological Features in 15 Cases
- 非小細胞肺癌術前輔助性化學治療的經驗
- Radiation Therapy in Primary Central Nervous System Lymphoma
- Nausea and Vomiting of Cancer Chemotherapy
頁籤選單縮合
題 名 | 乳癌婦女化療引起閉經之現象及其更年期症狀表現=Chemotherapy-Induced Amenorrhea and Menopause Symptoms in Women with Breast Cancer |
---|---|
作 者 | 李家瑩; 陳美伶; | 書刊名 | 護理雜誌 |
卷 期 | 63:5 2016.10[民105.10] |
頁 次 | 頁19-26 |
專 輯 | 婦女癌症護理 |
分類號 | 419.77 |
關鍵詞 | 乳癌婦女; 化學治療; 化療引起閉經; 更年期症狀; Breast cancer women; Chemotherapy; Chemotherapy-induced amenorrhea; CIA; Menopausal symptoms; |
語 文 | 中文(Chinese) |
中文摘要 | 化學治療(化療)為乳癌常見輔助治療,它可以藉由殺死殘餘癌細胞而提升乳癌的治療存活率。但化療藥物會破壞卵巢內生殖細胞,中斷女性生殖內分泌週期,使乳癌婦女出現化療引起閉經(chemotherapy-induced amenorrhea, CIA)現象。CIA發生率會因對閉經的定義不同而有不同,約有75%未停經乳癌婦女在接受化療後會產生CIA。年齡愈大、化療週期愈長、ER(estrogenreceptor)接受體為陽性及Tamoxifen的使用,均會提高CIA的風險。雖CIA可延長整體存活率及無病存活率,但也使婦女必須提早面對一系列因雌性激素下降所引發的更年期症狀(例如:認知功能、身體症狀、心理症狀、血管舒縮症狀、生殖及性功能、以及體重變化等)。本文描述了女性的生殖週期、CIA的機轉、CIA危險因子、CIA所引發的更年期症狀群及更年期症狀的評估方法,與五個常見評估症狀量表之比較。健康照護及研究者在了解所有可能的更年期症狀之後,可依情境需求選擇合適的評估工具,針對面臨更年期症狀的乳癌婦女進行症狀表現評估。 |
英文摘要 | Chemotherapy is a common adjuvant therapy for breast cancer that improves survival rates by killing residual cancer cells. However, this intervention may damage the germ cells within the ovary and interrupt the menstrual cycle, ultimately leading to chemotherapy-induced amenorrhea (CIA). The incidence of CIA depends on how broadly this term is defined. Around 75% of premenopausal breast cancer women treated with chemotherapy will develop CIA. Age, having a relatively long chemotherapy cycle duration, being estrogen-receptor positive, and using Tamoxifen all increase the risk of CIA. Although CIA may be associated with better prognosis outcomes, breast cancer women must subsequently deal with the various menopausal symptoms that are associated with a CIA-induced drop in estrogen level (such as cognitive function decline, physical and psychological symptoms, vasomotor symptoms, reproductive and sexual function problems, and body weight change). The present article describes the female menstrual cycle, the mechanism and risk factors of CIA, and the range of menopausal symptoms. Furthermore, we summarized methods of assessing menopausal symptoms and compared five common rating scales of menopausal symptoms. By better understanding the potential menopausal symptoms, researchers and clinicians may then select the most appropriate scale based on the situational needs in order to evaluate the severity of menopausal symptoms that are experienced by breast cancer women. |
本系統中英文摘要資訊取自各篇刊載內容。